Philanthropy-Backed Accelerator Advances Cancer Therapies dartmouth.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dartmouth.edu Daily Mail and Mail on Sunday newspapers.
Related Company:
Three teams receive awards from the Dartmouth Innovations Accelerator for Cancer
Vermont Business Magazine Three teams of Dartmouth researchers have been selected to receive the first awards from the Dartmouth Innovations Accelerator for Cancer.
A philanthropy-funded initiative, the Accelerator was launched in 2020 by Norris Cotton Cancer Center and the Magnuson Center for Entrepreneurship to bring new cancer treatments to patients more quickly. So far, it has raised $3.3 million in philanthropic gifts and seeks to hit $5 million by June. When you look at the number of biotech start-ups that have spun out of our cancer center, it s astounding, says Steven Leach, director of Dartmouth s and Dartmouth-Hitchcock s Norris Cotton Cancer Center and the Preston T. and Virginia R. Kelsey Chair in Cancer at the Geisel School of Medicine. The Accelerator builds on our culture of collaboration and innovation. In its first year, it has attracted 17 teams, including
Ohio State announces passing of longtime cancer genetics researcher Albert de la Chapelle
His work helped lead to the statewide Ohio Colorectal Cancer Prevention Initiative
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) has announced the passing of Dr. Albert de la Chapelle, a Distinguished University Professor in the Department of Cancer Biology and Genetics at Ohio State who played a key role in developing and leading the university’s human cancer genetics program to prominence.
De la Chapelle, 87, died Thursday of natural causes, just nine months after the March 2020 passing of his wife Clara D. Bloomfield, also a Distinguished University Professor who for many years served as cancer scholar and senior adviser to the OSUCCC – James. He was in the Cancer Biology Program and formerly co-led that program when it was known as Molecular Biology and Cancer Genetics.